LOSS OF CTLA-4 LEADS TO MASSIVE LYMPHOPROLIFERATION AND FATAL MULTIORGAN TISSUE DESTRUCTION, REVEALING A CRITICAL NEGATIVE REGULATORY ROLE OF CTLA-4

被引:2338
作者
TIVOL, EA [1 ]
BORRIELLO, F [1 ]
SCHWEITZER, AN [1 ]
LYNCH, WP [1 ]
BLUESTONE, JA [1 ]
SHARPE, AH [1 ]
机构
[1] UNIV CHICAGO,COMM IMMUNOL,CHICAGO,IL 60637
关键词
D O I
10.1016/1074-7613(95)90125-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The B7-CD28/CTLA-4 costimulatory pathway can provide a signal pivotal for T cell activation, Signaling through this pathway is complex due to the presence of two B7 family members, B7-1 and B7-2, and two counterreceptors, CD28 and CTLA-4. Studies with anti-CTLA-4 monoclonal antibodies have suggested both positive and negative roles for CTLA-4 in T cell activation, To elucidate the in vivo function of CTLA-4, we generated CTLA-4-deficient mice. These mice rapidly develop lymphoproliferative disease with multiorgan lymphocytic infiltration and tissue destruction, with particularly severe myocarditis and pancreatitis, and die by 3-4 weeks of age. The phenotype of the CTLA-4-deficient mouse strain is supported by studies that have suggested a negative role for CTLA-4 in T cell activation. The severe phenotype of mice lacking CTLA-4 implies a critical role for CTLA-4 in downregulating T cell activation and maintaining immunologic homeostasis. In the absence of CTLA-4, peripheral T cells are activated, can spontaneously proliferate, and may mediate lethal tissue injury.
引用
收藏
页码:541 / 547
页数:7
相关论文
共 30 条
  • [1] B70 ANTIGEN IS A 2ND LIGAND FOR CTLA-4 AND CD28
    AZUMA, M
    ITO, D
    YAGITA, H
    OKUMURA, K
    PHILLIPS, JH
    LANIER, LL
    SOMOZA, C
    [J]. NATURE, 1993, 366 (6450) : 76 - 79
  • [2] BLOCKADE OF THE CD28 COSTIMULATORY PATHWAY - A MEANS TO INDUCE TOLERANCE
    BOUSSIOTIS, VA
    GRIBBEN, JG
    FREEMAN, GJ
    NADLER, LM
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (05) : 797 - 807
  • [3] LONG-TERM INHIBITION OF MURINE EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS USING CTLA-4-FC SUPPORTS A KEY ROLE FOR CD28 COSTIMULATION
    CROSS, AH
    GIRARD, TJ
    GIACOLETTO, KS
    EVANS, RJ
    KEELING, RM
    LIN, RF
    TROTTER, JL
    KARR, RW
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) : 2783 - 2789
  • [4] TREATMENT OF MURINE LUPUS WITH CTLA4IG
    FINCK, BK
    LINSLEY, PS
    WOFSY, D
    [J]. SCIENCE, 1994, 265 (5176) : 1225 - 1227
  • [5] UNCOVERING OF FUNCTIONAL ALTERNATIVE CTLA-4 COUNTER-RECEPTOR IN B7-DEFICIENT MICE
    FREEMAN, GJ
    BORRIELLO, F
    HODES, RJ
    REISER, H
    HATHCOCK, KS
    LASZLO, G
    MCKNIGHT, AJ
    KIM, J
    DU, LN
    LOMBARD, DB
    GRAY, GS
    NADLER, LM
    SHARPE, AH
    [J]. SCIENCE, 1993, 262 (5135) : 907 - 909
  • [6] CLONING OF B7-2 - A CTLA-4 COUNTER-RECEPTOR THAT COSTIMULATES HUMAN T-CELL PROLIFERATION
    FREEMAN, GJ
    GRIBBEN, JG
    BOUSSIOTIS, VA
    NG, JW
    RESTIVO, VA
    LOMBARD, LA
    GRAY, GS
    NADLER, LM
    [J]. SCIENCE, 1993, 262 (5135) : 909 - 911
  • [7] FREEMAN GJ, 1992, J IMMUNOL, V149, P3795
  • [8] MURINE B7-2, AN ALTERNATIVE CTLA4 COUNTER-RECEPTOR THAT COSTIMULATES T-CELL PROLIFERATION AND INTERLEUKIN-2 PRODUCTION
    FREEMAN, GJ
    BORRIELLO, F
    HODES, RJ
    REISER, H
    GRIBBEN, JG
    NG, JW
    KIM, J
    GOLDBERG, JM
    HATHCOCK, K
    LASZLO, G
    LOMBARD, LA
    WANG, S
    GRAY, GS
    NADLER, LM
    SHARPE, AH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) : 2185 - 2192
  • [9] GREENFIELD CL, 1994, P NATL ACAD SCI USA, V92, P811
  • [10] HARPER K, 1991, J IMMUNOL, V147, P1037